These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 17891927

  • 1. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
    Sívori M, Rodríguez GE, Pascansky D, Sáenz C, Sica RE.
    Medicina (B Aires); 2007; 67(4):326-30. PubMed ID: 17891927
    [Abstract] [Full Text] [Related]

  • 2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG, Mitchell JD, Lyon M, Moore DH.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [Abstract] [Full Text] [Related]

  • 3. Early use of non-invasive ventilation prolongs survival in subjects with ALS.
    Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM.
    Amyotroph Lateral Scler; 2007 Jun; 8(3):185-8. PubMed ID: 17538782
    [Abstract] [Full Text] [Related]

  • 4. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O.
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [Abstract] [Full Text] [Related]

  • 5. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.
    Peysson S, Vandenberghe N, Philit F, Vial C, Petitjean T, Bouhour F, Bayle JY, Broussolle E.
    Eur Neurol; 2008 Apr; 59(3-4):164-71. PubMed ID: 18230874
    [Abstract] [Full Text] [Related]

  • 6. [Physiological parameters of breathing and the impact of non-invasive ventilation (NIV) on patients with amyotrophic lateral sclerosis (ALS)].
    Czudaj KP, Suchi S, Schönhofer B.
    Pneumologie; 2009 Dec; 63(12):687-92. PubMed ID: 19890778
    [Abstract] [Full Text] [Related]

  • 7. Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients.
    Pinto A, de Carvalho M, Evangelista T, Lopes A, Sales-Luís L.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):31-5. PubMed ID: 12745616
    [Abstract] [Full Text] [Related]

  • 8. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G, SLAP registry.
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [Abstract] [Full Text] [Related]

  • 9. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F, Shinoda K, Fujiwara S, Fujimura C, Nakajima H, Furutama D, Sugino M, Hanafusa T.
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [Abstract] [Full Text] [Related]

  • 10. The effect of noninvasive ventilation on ALS patients and their caregivers.
    Mustfa N, Walsh E, Bryant V, Lyall RA, Addington-Hall J, Goldstein LH, Donaldson N, Polkey MI, Moxham J, Leigh PN.
    Neurology; 2006 Apr 25; 66(8):1211-7. PubMed ID: 16636239
    [Abstract] [Full Text] [Related]

  • 11. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC, Burke D, Pamphlett R, Kiernan MC.
    J Clin Neurosci; 2006 Jan 25; 13(1):78-83. PubMed ID: 16410201
    [Abstract] [Full Text] [Related]

  • 12. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Zis V, Sfagos C, Vassilopoulos D.
    Clin Neurol Neurosurg; 2008 Mar 25; 110(3):222-6. PubMed ID: 18055102
    [Abstract] [Full Text] [Related]

  • 13. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S, Lin CS, Cheah BC, Murray J, Menon P, Krishnan AV, Kiernan MC.
    Brain; 2013 May 25; 136(Pt 5):1361-70. PubMed ID: 23616585
    [Abstract] [Full Text] [Related]

  • 14. Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis.
    Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL.
    Muscle Nerve; 2005 Dec 25; 32(6):808-11. PubMed ID: 16094653
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole.
    Paillisse C, Lacomblez L, Dib M, Bensimon G, Garcia-Acosta S, Meininger V.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar 25; 6(1):37-44. PubMed ID: 16036424
    [Abstract] [Full Text] [Related]

  • 16. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.
    Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ.
    Lancet Neurol; 2006 Feb 25; 5(2):140-7. PubMed ID: 16426990
    [Abstract] [Full Text] [Related]

  • 17. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
    Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar 25; 3(1):15-21. PubMed ID: 12061944
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I, Camu W, Hillaire-Buys D.
    Therapie; 2000 Mar 25; 55(2):303-12. PubMed ID: 10967703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.